For the quarter ending 2026-03-31, AUPH made $77,705K in revenue. $34,074K in net income. Net profit margin of 43.85%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue | 77,705 | 77,114 | 73,468 | 70,008 |
| Cost of revenue | 6,505 | 8,799 | 8,177 | 7,115 |
| Selling, general and administrative | 22,029 | 29,255 | 26,182 | 26,018 |
| Research and development | 7,470 | 10,895 | 8,435 | 7,432 |
| Restructuring | 0 | 0 | 0 | 114 |
| Other expense, net | -279 | 5,074 | -929 | -9,246 |
| Total operating expenses | 36,283 | 43,875 | 43,723 | 49,925 |
| Income from operations | 41,422 | 33,239 | 29,745 | 20,083 |
| Interest income | 3,515 | 3,498 | 3,316 | 3,190 |
| Interest expense | 1,012 | 1,047 | 1,099 | 1,117 |
| Net income before income taxes | 43,925 | 35,690 | 31,962 | 22,156 |
| Income tax expense | 9,570 | -175,104 | 411 | 643 |
| Net income | 34,355 | 210,794 | 31,551 | 21,513 |
| Unrealized loss on available-for-sale securities | -281 | 150 | 156 | -80 |
| Comprehensive income | 34,074 | 210,944 | 31,707 | 21,433 |
| Basic EPS | 0.26 | 1.6 | 0.24 | 0.16 |
| Diluted EPS | 0.25 | 1.528 | 0.23 | 0.16 |
| Basic Average Shares | 132,375,000 | 131,870,000 | 131,808,000 | 134,873,000 |
| Diluted Average Shares | 137,639,000 | 138,067,000 | 136,008,000 | 137,526,000 |
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH)